(Q38253124)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

28 May 2020

New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Yi-Xin Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Wei Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Zu-Liang Jie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Hui Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Wei Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Yi-Xin Huang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

English

0 references

publication date

19 September 2014

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

28 May 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

28 May 2020

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

15058-15074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

17 February 2020

copyright license

1 reference

28 May 2020

0 references

Human schistosomiasis

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Parasites and poverty: the case of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Schistosomiasis japonica control and research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Assessment of morbidity due to Schistosoma japonicum infection in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Monitoring the transmission of Schistosoma japonicum in potential risk regions of China, 2008 - 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Dynamics of spatial clustering of schistosomiasis in the Yangtze River Valley at the end of and following the World Bank Loan Project

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Reduction patterns of acute schistosomiasis in the People's Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Epidemiology of schistosomiasis in the People's Republic of China, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Praziquantel: an urgent and exciting challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Susceptibility or resistance of praziquantel in human schistosomiasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Resistance of Schistosoma mansoni to praziquantel: is there a problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Schistosomiasis haematobia: histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Application of praziquantel in schistosomiasis japonica control strategies in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Research and development of antischistosomal drugs in the People's Republic of China a 60-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

The sensitivity of Schistosoma japonicum to praziquantel: a field evaluation in areas with low endemicity of China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Human schistosomiasis resistance to praziquantel in China: should we be worried?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Will new antischistosomal drugs finally emerge?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Artemisinin: discovery from the Chinese herbal garden

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Artemisinin and its derivatives: an important new class of antimalarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Malaria and artemisinin derivatives: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Antimalarial compounds: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Artemisinin and derivatives: the future for malaria treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Artemisinin: the gifts from traditional Chinese medicine not only for malaria control but also for schistosomiasis control

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

New insight into praziquantel against various developmental stages of schistosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

The prophylactic effects of artemether against Schistosoma japonicum infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

In-vivo activity of dihydroartemisinin against Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Dihydroartemisinin-praziquantel combinations and multiple doses of dihydroartemisinin in the treatment of Schistosoma japonicum in experimentally infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Artemether administered together with haemin damages schistosomes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Schistosoma japonicum: effect of artemether on glutathione S-transferase and superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Time to set the agenda for schistosomiasis elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Artemisinins: pharmacological actions beyond anti-malarial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Anticancer activities of artemisinin and its bioactive derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES190915058

Effect of artemether on glucose uptake and glycogen content in Schistosoma japonicum.

21 January 2018

1 reference

12 December 2020

Use of artemisinin derivatives for the control of malaria.

1 reference

12 December 2020

Preventive effect of artemether on schistosome infection.

1 reference

12 December 2020

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

1 reference

12 December 2020

Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits

1 reference

12 December 2020

Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome

1 reference

12 December 2020

Schistosoma japonicum: In vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media

1 reference

12 December 2020

1 reference

12 December 2020

Artemisinin induces apoptosis in human cancer cells.

1 reference

12 December 2020

Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection

1 reference

12 December 2020

Schistosome resistance to praziquantel

1 reference

12 December 2020

Artemisinins for schistosomiasis and beyond.

1 reference

12 December 2020

Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails

1 reference

12 December 2020

Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis

1 reference

12 December 2020

[Advances in research of dihydroartemisinin against parasitic diseases]

1 reference

12 December 2020

[Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory]

1 reference

12 December 2020

[Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercaria

1 reference

12 December 2020

Antimalarials in the treatment of schistosomiasis.

1 reference

12 December 2020

Artesunate effect on schistosome thioredoxin glutathione reductase and cytochrome c peroxidase as new molecular targets in schistosoma mansoni-infected mice.

1 reference

12 December 2020

[Studies on the efficacy of artemether in experimental schistosomiasis (author's transl)]

1 reference

12 December 2020

Antischistosomal action of some Qing Hao Su derivatives in infected mice (author's transl)

1 reference

12 December 2020

Effect of artemether on glycogen, protein, alkaline phosphatase and acid phosphatase of Schistosoma japonicum

1 reference

12 December 2020

Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

1 reference

12 December 2020

Experimental studies on early treatment of schistosomal infection with artemether

1 reference

12 December 2020

Field studies on the preventive effect of oral artemether against schistosomal infection

1 reference

12 December 2020

Studies on prophylactic effect of artesunate on schistosomiasis japonica

1 reference

12 December 2020

10.3390/MOLECULES190915058

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

PubMed publication ID

25244286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25244286%20AND%20SRC:MED&resulttype=core&format=json